Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0598853 (forgetting)
 3,232 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Marijuana and its psychoactive constituents induce a multitude of effects on brain function. These include deficits in memory formation, but care needs to be exercised since many human studies are flawed by multiple drug abuse, small sample sizes, sample selection and sensitivity of psychological tests for subtle differences. The most robust finding with respect to memory is a deficit in working and short-term memory. This requires intact hippocampus and prefrontal cortex, two brain regions richly expressing CB1 receptors. Animal studies, which enable a more controlled drug regime and more constant behavioural testing, have confirmed human results and suggest, with respect to hippocampus, that exogenous cannabinoid treatment selectively affects encoding processes. This may be different in other brain areas, for instance the amygdala, where a predominant involvement in memory consolidation and forgetting has been firmly established. While cannabinoid receptor agonists impair memory formation, antagonists reverse these deficits or act as memory enhancers. These results are in good agreement with data obtained from electrophysiological recordings, which reveal reduction in neural plasticity following cannabinoid treatment, and increased plasticity following antagonist exposure. The mixed receptor properties of the pharmacological tool, however, make it difficult to define the exact role of any CB1 receptor population in memory processes with any certainty. This makes it all the more important that behavioural studies use selective administration of drugs to specific brain areas, rather than global administration to whole animals. The emerging role of the endogenous cannabinoid system in the hippocampus may be to facilitate the induction of long-term potentiation/the encoding of information. Administration of exogenous selective CB1 agonists may therefore disrupt hippocampus-dependent learning and memory by 'increasing the noise', rather than 'decreasing the signal' at potentiated inputs.
 ...
PMID:Cannabinoid function in learning, memory and plasticity. 1659 84

Research into the cognitive consequences of chronic excessive alcohol use continues to grow. Despite this, little research has investigated what impact excessive alcohol use might have upon everyday remembering. An important aspect of everyday remembering is prospective memory (PM), which refers to the cognitive ability of remembering to carry out an intended action at some future point in time. The majority of the studies which have focused on what impact excessive alcohol use has upon PM in teenagers and young adults have consistently found that the excessive drinkers reported more lapses in their short term (e.g., forgetting to lock one's door upon leaving home) and long term (e.g., forgetting to post a letter on time) aspects of everyday PM, when compared to low-dose alcohol users or non-users. It is concluded from this review that PM deficits should be added to the growing list of neuropsychological sequelae associated with excessive alcohol use. The magnitude of the effects of alcohol on PM depends upon the amount of alcohol consumed and how long one has been drinking. Major limitations of these studies include their reliance upon the use of self-report measures of PM, the issue of polydrug use complicating the picture, the need to control for the co-morbidity of other conditions--such as depression, and better drug-screening methods. Therefore, further studies need to employ objective measures alongside self-report measures of PM, incorporate better controls for the use of other drugs and mood states, as well as extending the focus of the research to study what effect different patterns of alcohol use might have upon PM, e.g., what impact binge drinking has upon everyday PM. These findings have educational and applied relevance within the alcohol field.
Curr Drug Abuse Rev 2008 Jan
PMID:The impact of excessive alcohol use on prospective memory: a brief review. 1963 Jul 3

Health-related psychedelic research should focus on helping us flourish, not just remedying ill-health or addiction. We don't know enough about how psychedelics could enhance human flourishing. Factors promoting health-through-flourishing include finding meaning in life, spiritual practices, comfortable levels of social bonds, emotionally/physically satisfying sex in a long-term monogamous relationship and control over one's daily life. Psychedelic research could find more. Neuroscience anchors psychedelic research into disease and disorder, e.g. addiction, PSTD, migraine, anxiety, pain etc. Neurophenomenological psychedelics research could illuminate relationships between health, ASC/NOSCs and cognitive liberty to promote human flourishing. If we accept the self as an epiphenomenon of subsystems within the brain, we 'know' 'unconsciously', but are not aware of, many things which affect our lives profoundly. These include control over identifying, remembering and forgetting our states of mind and how to move between them. A prerequisite for integrated investigations into ASC/NOSCs is the establishment of a taxonomic knowledge base which lists, categorises and characterises ASC/NOSCs to enable us to choose specific states of mind and move securely among them. Or, in other words, to enable us to exercise our cognitive liberty safely. I believe that human health and flourishing would be enhanced were we able to direct our states of being by consciously choosing them. Given the promise of mindfulness techniques to enhance our health, happiness and spiritual growth, constructing both personal and generic classifications of salient ASC/NOSCs makes sense. Laws need to change. The neuroscience of pleasure, love, spirituality, decision-making, pattern recognition and location of meaning should inform health-enhancing psychedelic research while promoting flourishing through cognitive liberty. As part of cognitive liberty, our end-of-life choices should include how we die. In other words, our idea of the good death should include access to psychedelics. Dying high is increasingly likely to become a popular choice as baby boomers age and place their economic clout behind the reform of end-of-life laws as well as drug laws. Achieving such crucial legal changes depends partly on the ability to produce research to anchor evidence based law and policy. Research into psychedelics, ASC/NOSCs and the neurobiology of the dying process is essential.
Curr Drug Abuse Rev 2014
PMID:What can neuroscience tell us about the potential of psychedelics in healthcare? How the neurophenomenology of psychedelics research could help us to flourish throughout our lives, as well as to enhance our dying. 2556 49